Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Healthcare Global Enterprises Ltd. Share Price
Day's Range
Day's Range
Low
₹646.70
High
₹670.75
Price Summary
| Previous Close | ₹666.40 |
|---|---|
| Day's Range | ₹646.70 - ₹670.75 |
| Open | ₹656.00 |
| 52 Week Range | ₹513.30 - ₹799.71 |
| Volume | 2,73,486 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1,819.24 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 724.65 |
| TTM EPS (₹) | 0.92 |
| P/E Ratio | 168.91 |
| Book Value(₹) | 7.49 |
| PAT Margin (%) | 2.20 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 12.36 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 22228.5 | 5851.6 |
| Expenses | N/A | N/A |
| PBT | 569.6 | 136.2 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 488.3 | 67.7 |
About Healthcare Global Enterprises Ltd.
| Founded | 1998 |
|---|---|
| NSE Symbol | HCG |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,64,331.30 | 1,935.25 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,81,466.36 | 6,832.30 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,65,951.64 | 4,895.20 | 3,309.40 - 3,309.40 |
| Apollo Hospitals Enterprise Ltd. | 1,27,127.92 | 8,843.70 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,228.74 | 1,438.75 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,14,762.82 | 1,150.50 | 835.50 - 835.50 |
| Lupin Ltd. | 1,14,128.12 | 2,496.90 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,07,853.30 | 1,108.15 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,04,275.29 | 2,526.55 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,03,958.87 | 1,245.50 | 1,148.40 - 1,148.40 |
No Records Found
Latest News
HealthCare Global Enterprises submits scrutinizer’s report and voting results
HealthCare Global Enterprises has informed that, pursuant to provisions of Section 110 of the Companies Act, 2013, read with Rule 22 of the Companies (Management and Administration) Rules, 2014, Regulation 44(3) of SEBI Listing Regulations, and further to its intimation to Stock Exchanges on June 08, 2026, the approval of members of the Company was sought by remote e-voting process in respect of the resolutions set out in the Postal Ballot Notice dated June 08, 2026. In this regard, it enclosed the following: (i) Voting Results in compliance with Regulation 44(3) of SEBI Listing Regulations; and (ii) Consolidated Report of the Scrutinizer dated July 09, 2026, issued by, V Sreedharan, Senior Partner, V Sreedharan and Associates, Company Secretaries, on the remote e-voting conducted through the Postal Ballot process, pursuant to the provisions of Section 110 of the Companies Act, 2013 read with Rule 22 of the Companies (Management and Administration) Rules, 2014. Detailed information in this regard in accordance with Regulation 30 read with SEBI Circulars SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026, is annexed as Annexure-A. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/.
The above information is a part of company’s filings submitted to BSE.
HealthCare Global Enterprises informs about updates
HealthCare Global Enterprises informs about statement of deviation or variation
Pursuant to the Listing Regulations, HealthCare Global Enterprises has confirmed that there were no deviations or variations in the utilisation of the proceeds raised through the Rights Issue of the Company during the quarter ended March 31, 2026, from the objects stated in the Letter of Offer dated February 24, 2026. In this regard, it has enclosed, as Annexure, the statement confirming that there was no deviation or variation in the utilisation of the aforesaid proceeds for the quarter ended March 31, 2026, from the objects stated in the Letter of Offer, in accordance with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019. The said statement has been duly reviewed by the Audit Committee of the Company. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/.
The above information is a part of company’s filings submitted to BSE.
HealthCare Global Enterprises informs about press release
HealthCare Global Enterprises informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Healthcare Global Enterprises Ltd. is ₹666.40 as of 2026-07-10.
The market capitalisation of Healthcare Global Enterprises Ltd. is ₹9,971.15 as of 2026-07-10.
The 1-year return of Healthcare Global Enterprises Ltd. is 110.73% as of 2026-07-10.
The P/E ratio of Healthcare Global Enterprises Ltd. is 168.91 as of 2026-07-12.
The 52-week high and low of Healthcare Global Enterprises Ltd. are ₹799.71 and ₹513.30, respectively, as of 2026-07-10.
People Also Ask
Healthcare Global Enterprises Limited (HCG) provides specialised cancer care, oncology treatments, diagnostics, preventive healthcare, and multidisciplinary medical services. The company operates a network of cancer centres and hospitals offering advanced treatment, screening, rehabilitation, and supportive care services.
Healthcare Global Enterprises Limited was established in 1989. The company focuses on oncology services and operates cancer care centres, hospitals, and diagnostic facilities across India.
Healthcare Global Enterprises Limited is listed on the National Stock Exchange under the symbol HCG. Investors can access company-related announcements, financial disclosures, and trading information through stock exchange platforms.
Healthcare Global Enterprises Limited is a publicly listed healthcare company with participation from promoters, institutional investors, mutual funds, foreign investors, and public shareholders.
Healthcare Global Enterprises Limited is headquartered in Bengaluru, Karnataka. The company manages its hospital network, oncology centres, healthcare operations, and strategic initiatives through its corporate office.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
